Current location:


Choose your location:

Varicella Vaccine, Live - PROVARIX

Launched in 2020.

  • Prequalified by the World Health Organization.

  • Independently developed SV-1 human diploid cell line has clear traceability and is safe and stable.

  • Phase III clinical trial results have demonstrated strong protective efficacy, with a 100% prevention rate for moderate and severe cases.

  • Virus released through physical means with no chemical residue. Adds no large molecular substances, for a simpler, safer composition.